abstract |
Angiogenesis inhibitors and methods of use are provided. The present disclosure generally relates to treating or preventing a disease associated with angiogenesis by administering to a patient certain compounds that have been found to inhibit or significantly reduce angiogenesis. The compound used in the present disclosure exhibits a preventive effect for preventing and significantly reducing angiogenesis, and also exhibits a good angiogenesis inhibitory activity. Examples of the compound include ritanserin, amiodarone, terfenadine, perphenazine, bitionol, and clomipramine. [Selection] Figure 5 |